Literature DB >> 16434817

Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model.

Daisuke Sato1, Shinichi Niwano, Ryuta Imaki, Yoshihiko Masaki, Sae Sasaki, Masaru Yuge, Shoji Hirasawa, Takeshi Sasaki, Masahiko Moriguchi, Hiroe Niwano, Hirokuni Yoshimura, Tohru Izumi.   

Abstract

Background The effect of bepridil, a multichannel blocker, on atrial electrical remodeling was evaluated in a canine rapid atrial stimulation model. Methods and Results In 10 beagle dogs, the right atrial appendage (RAA) was paced at 400 beats/min for 2 weeks. The atrial electrophysiological parameters, including effective refractory period (AERP), were evaluated at three atrial sites: RAA, the right atrium close to the inferior vena cava (IVC) and the left atrium (LA), during the time course of rapid pacing. Five of the dogs were given bepridil (10 mg . kg (-1) . day(-1) po). In the control group, AERP was significantly shortened at all atrial sites and the AERP shortening (DeltaAERP) was larger for the RAA and LA than at the IVC site (p<0.05). In the bepridil group, DeltaAERP was smaller than that of the controls at all atrial sites, and the AERP started to return slowly to the pre-pacing level in the second week, regardless of the continuation of rapid pacing. Conclusions In a canine rapid atrial stimulation model, bepridil suppressed AERP shortening. Bepridil might have a reverse electrical remodeling effect, at least for AERP shortening, because it showed slow recovery of AERP in the subacute phase of rapid atrial pacing. (Circ J 2006; 70: 206 - 213).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434817     DOI: 10.1253/circj.70.206

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

Review 1.  Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.

Authors:  Narutaka Ohashi; Hideo Mitamura; Satoshi Ogawa
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation.

Authors:  Akira Satoh; Shinichi Niwano; Hiroe Niwano; Jun Kishihara; Yuya Aoyama; Jun Oikawa; Hidehira Fukaya; Hideaki Tamaki; Junya Ako
Journal:  Heart Vessels       Date:  2016-07-11       Impact factor: 2.037

3.  Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil.

Authors:  Fangfang Ma; Hiroki Takanari; Kimiko Masuda; Masaki Morishima; Katsushige Ono
Journal:  Heart Vessels       Date:  2015-10-26       Impact factor: 2.037

4.  Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation.

Authors:  Daisuke Yakabe; Yusuke Fukuyama; Masahiro Araki; Toshihiro Nakamura
Journal:  J Arrhythm       Date:  2021-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.